MABSKY
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
MABSKY - overview
Established
2004
Location
Shenzhen, Guangdong, China
Primary Industry
Biotechnology
About
Based in Guangdong, China, and founded in in 2004, MABSKY BIO-TECH CO. ，LTD, trading as MABSKY, is a high-tech company specialized in the R&D, production and marketing of molecular biological and immunological diagnostic products. In 2020 and 2021, Med Captain fully acquired MABSKY. Leveraging technology platforms for molecular diagnostics (fluorescent PCR) and immunodiagnostics, the company has developed over 300 types of IVD reagents and instruments.
These products are widely used in clinical medicine, public health emergency responses, entry-exit inspection and quarantine, food safety, and other fields. The company’s revenue is generated by providing molecular biological and immunological diagnostic products.
Current Investors
Med Captain
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biotechnology, Pharmaceuticals
Verticals
HealthTech, Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
MABSKY - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | MABSKY | - | ||||||||
| Add-on | Completed | MABSKY | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.